HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Paul E. Van Schil Jeroen M. Hendriks Bernard A. Stockman Patrick R. Lauwers Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Van Schil, P. E. Articles by Schramel, F. M. Search for Related Content PubMed PubMed Citation Articles by Van Schil, P. E. Articles by Schramel, F. M. Related Collections Lung - cancer Extracorporeal circulation History

Review

Isolated lung perfusion and related techniques for the treatment of pulmonary metastases

^a Department of Thoracic and Vascular Surgery, University of Antwerp, Belgium
^b Department of Cardiac Surgery, University of Antwerp, Belgium
^c Department of Anaesthesiology, University of Antwerp, Belgium
^d Department of Pulmonary Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands
^e Department of Thoracic Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands

Received 8 September 2007; received in revised form 15 November 2007; accepted 10 December 2007.

^_* Corresponding author. Address: Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Wilrijkstraat 10, B-2650 Edegem, Antwerp, Belgium. Tel.: +32 3 8214360; fax: +32 3 8214396. (Email: paul.van.schil{at}uza.be).

Surgical resection is a widely accepted treatment for pulmonary metastases on the condition that a complete resection can be obtained. However, many patients will develop recurrent disease in the thorax despite the use of systemic chemotherapy, dosage of which is limited because of systemic toxicity. Similar to the basic principles of isolated limb and liver perfusion, isolated lung perfusion is an attractive and promising surgical technique for the delivery of high-dose chemotherapy with minimal systemic toxicity. The use of biological response modifiers, like tumour necrosis factor, is also feasible. Other related methods of delivering high-dose locoregional chemotherapy include embolic trapping (chemo-embolisation) and pulmonary artery infusion without control of the venous effluent.

Isolated lung perfusion has proven to be highly effective in experimental models of pulmonary metastases with a clear survival advantage. Lung levels of cytostatic drugs are significantly higher after isolated lung perfusion compared to intravenous therapy without systemic exposure. Phase I human studies have shown that isolated lung perfusion is technically feasible with low morbidity and without compromising the patient's pulmonary function. Further clinical studies are necessary to determine its definitive effect on local recurrence, long-term toxicity, pulmonary function and survival.

Key Words: Pulmonary metastases • Surgery • Chemotherapy • Locoregional therapy • Isolated lung perfusion • Combined modality therapy

This article has been cited by other articles:

				L. Erhunmwunsee and T. A. D'Amico Surgical management of pulmonary metastases. Ann. Thorac. Surg., December 1, 2009; 88(6): 2052 - 2060. [Abstract] [Full Text] [PDF]